Your partner in science for end-to-end CRDMO solutions
In vitro Biology & Pharmacology Solutions
The In vitro Biology Group has the expertise to perform a variety of biochemical and cellular assays against varied target classes, including enzymes, GPCR’s, NHR’s and transporters.
Our facility is equipped with necessary infrastructure and updated technologies for in vitro pharmacology services to enable these undertakings, supported by liquid-handlers, compound-managers and multi-mode detection systems.
With a high ratio of PhD scientists with global exposure and long-standing discovery experience, Jubilant Biosys is well-placed to support target validation, assay development, screening and mechanism of action for first-in-class & best-in-class requirements.
The following functional services are provided:
- Biochemical based assay development, validation & screening
- Biophysical assay development, validation & screening
- Cell-based assay development, validation & screening
- Immune-cell based development, validation & screening
Assay Technologies
- Absorbance
- Fluorescence – FP, TR-FRET, HTRF, Lance
- Luminescence and alpha technology
- ELISA, FACS
- Traditional, JESS, LYCOR
- FLIPR Penta
- Radiometric – SPA, Filter Binding, Flash Plate
- Label free approaches
Our experienced team of in vitro pharmacology brings strong problem-solving skills and expertise in a large variety of assays involving platforms mentioned above.
Biology Assay Development & Validation
Our biologists assist with appropriate and aminable assays to screen small molecules and support discovery from hit-to-lead, lead to optimization to preclinical candidate.
Our expertise lies in various therapeutic areas, including oncology, CNS, metabolic disorders, pain & inflammation.
We have successfully delivered over 85 IDD programs including first-in-class and best-in-class requirements for leading pharma & biotech companies.
